International Research Journal of Innovations in Engineering and Technology - IRJIET International Open Access, Monthly, Peer Reviewed, Reputed Journal ISSN (online): 2581-3048

Impact Factor (2025): 6.9

DOI Prefix: 10.47001/IRJIET

Forecasting Covid-19 New Cases in Monaco

Abstract

In this study, the ANN approach was applied to analyze COVID-19 new cases in Monaco. The employed data covers the period 1 January 2020 – 25 March 2021 and the out-of-sample period ranges over the period 26 March – 31 July 2021. The residuals and forecast evaluation criteria (Error, MSE and MAE) of the applied model indicate that the model is quite stable. The results of the study indicate that daily COVID-19 cases in Monaco are likely to remain between 10 and 30 cases per day over the out-of-sample period. Amongst other suggested policy directions, there is need for the government of Monaco to ensure adherence to safety guidelines while continuing to create awareness about the COVID-19 pandemic.

Country : Zimbabwe

1 Dr. Smartson. P. NYONI2 Mr. Thabani NYONI3 Mr. Tatenda. A. CHIHOHO

  1. ZICHIRe Project, University of Zimbabwe, Harare, Zimbabwe
  2. SAGIT Innovation Center, Harare, Zimbabwe
  3. Independent Health Economist, Harare, Zimbabwe

IRJIET, Volume 5, Issue 6, June 2021 pp. 347-352

doi.org/10.47001/IRJIET/2021.506061

Full Paper
Download

References

  1. World Health Organization (2020). “Coronavirus disease 2019 (COVID-19)” Situation Rep. 67.
  2. M. T. P. Coelho et al., Exponential phase of covid19 expansion is not driven by climate at global scale. medRxiv:10.1101/2020.04.02.20050773 (6 May 2020).
  3. E. Dong, H. Du, L. Gardner, An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533–534 (2020)
  4. N. Ferguson et al., “Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand” (Rep. 9, Imperial College London, 2020)
  5. Tang. B et al (2020).  An updated estimation of the risk of transmission of the novel coronavirus (2019-nCoV). Infectious Disease Modelling 5, 248–255.
  6. Tang. B et al (2020). Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J. Clinical Med. 9, 462.
  7. Wang D et al (2020).  Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323, 1061–1069.
  8. Wang H et al (2020). Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China. Cell Discovery 6, 76.
  9. Wang. W et al (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virology 92, 441–447
  10. CDC (2020). The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. China CDC Weekly 2, 113–122.

Copyright @ 2026-2017 IRJIET. All Right Reserved.

Developed by Byzero Technologies